Current Clinical Trial Management Solutions used by almost all pharmaceutical and biotech companies support a minimal scope of functionality, focused only on planning and executing trials from an operations view.
While the core functions have been updated and refined with most vendors, the real value of CTMS is realized when data is used to select the best performing investigators, support a more advanced risk-based monitoring approach and assist with advanced online patient recruitment.
In this whitepaper we are looking closer at some of the capabilities we believe are important to consider when selecting a new solution.